Snowball logo
logo
ORMP

Oramed Pharmaceuticals Inc

ORMP β€’ TA
β‚ͺ13.02-β‚ͺ0.01Β  (0.08%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
2.7032.7032.703-1.999999-
COGS
---0.7032241.9869990.264372
Gross Profit
2.703-2.703(0.703224)0.013(0.264372)
Operating Expenses & Income
Operating Income
(24.22)(40.6)(40.6)(12.78)(15.09)(14.27)
Total Operating Expenses
26.9343.343.312.7815.119.72
R&D Expenses
20.9927.6427.646.3246.3809998.446847
Selling General & Admin Expenses
5.93715.6613.816.4578.728.478
Earnings from Continuing Operations
Interest Expense
--(2.037)(0.853)--
Interest Income
0.3473.5738.1694.9982.37315.64
Income Tax Expense
(2.878)-0.13.18311.3121.92
Net Income
Net Income
(22.24)(36.56)(37.76)(19.06)64.05110.2
Supplemental
EBIT
(25.12)-(40.6)(12.78)(15.09)47.61
EBITDA
(25.04)-(36.98)(12.59)(14.97)47.73
In millions of ILS, except % and values per 1 share